Results 241 to 250 of about 821,293 (407)
Atezolizumab-induced vanishing bile duct syndrome: a case report. [PDF]
Noblejas Quiles CT +9 more
europepmc +1 more source
Systemic Toxicity of L‐Mimosine in Rabbits: A Non‐Rodent Model for Safety Assessment
ABSTRACT L‐mimosine is a non‐protein amino acid primarily found in the Mimosoideae subfamily, with high concentrations in Leucaena leucocephala and Mimosa pudica. These plants are widely used in both human and animal nutrition, as well as in phytotherapeutic applications. While the toxic effects of L‐mimosine have been extensively studied in ruminants,
S. M. Ferreira +6 more
wiley +1 more source
Common bile duct stent-stone complex: the silent threat of forgotten biliary stents-case series. [PDF]
Parshaila R +4 more
europepmc +1 more source
The PIVKA‐II produced by HCC may differ from that produced by obstructive jaundice and sepsis. Given that serum PIVKA‐II levels are abnormally elevated in patients with obstructive jaundice and sepsis, the results should be interpreted with caution in patients with hepatocellular carcinoma combined with these diseases. ABSTRACT Background PIVKA‐II is a
Ke Zhang, Xiarui Ye, Xianran Fu
wiley +1 more source
Reconstruction of Iatrogenic Bile Duct Injuries following Laparoscopic Cholecystectomy. [PDF]
Hadi A, Khan I, Shah FO.
europepmc +1 more source
ABSTRACT Background Congenital biliary dilatation (CBD) is a rare anomaly often treated surgically, yet postoperative complications remain a concern. This study aimed to evaluate the incidence, timing, and risk factors of such complications after CBD surgery.
Takuya Maeda +9 more
wiley +1 more source
Evolving Strategies for the Optimal Management of Common Bile Duct Stones. [PDF]
Chon HK, Jo IH, Park CH.
europepmc +1 more source

